Furthermore, interfering with ACSL4-dependent ferroptosis clearly reduces HCC progression in the well-established toxic injury model (DEN-CCl4), most likely as a result of diminished fibrosis upon Acsl4 deletion. Here, ACSL4 is linked to hepatocellular carcinoma.